封面
市场调查报告书
商品编码
1980794

全球血栓管理设备市场规模、份额、趋势和成长分析报告(2026-2034年)

Global Clot Management Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034

出版日期: | 出版商: Value Market Research | 英文 137 Pages | 商品交期: 最快1-2个工作天内

价格
简介目录

预计血栓管理设备的市场规模将从 2025 年的 17.1 亿美元成长到 2034 年的 27.3 亿美元,2026 年至 2034 年的复合年增长率为 5.34%。

由于心血管疾病和血栓性疾病的发生率不断上升,全球血栓管理器械市场正经历显着增长。血栓可导致中风、肺动脉栓塞和深层静脉栓塞症等严重,因此,在急诊医疗中,有效的血栓切除和治疗至关重要。血栓管理器械广泛应用于介入手术中,用于清除或溶解血栓,恢復正常血流。

技术进步显着提升了血栓治疗设备的性能和安全性。机械血栓切除系统、抽吸导管和血栓移除装置使医生能够更精准、更快速地治疗血栓性疾病。微创治疗技术的日益普及进一步推动了该市场的成长。

随着医疗机构持续专注于先进的心血管治疗方案,全球血栓管理设备市场预计将会扩大。製造商正在研发新一代设备,以提高血栓切除术的效率并降低手术风险。随着中风和其他血栓性疾病发病率的上升,对有效血栓管理技术的需求预计将显着增长。

目录

第一章:引言

第二章执行摘要

第三章 市场变数、趋势与框架

  • 市场谱系展望
  • 渗透率和成长前景分析
  • 价值链分析
  • 法律规范
    • 标准与合规性
    • 监管影响分析
  • 市场动态
    • 市场驱动因素
    • 市场限制因素
    • 市场机会
    • 市场挑战
  • 波特五力分析
  • PESTLE分析

第四章 全球血栓管理设备市场:依产品分类

  • 市场分析、洞察与预测
  • 神经血管栓塞清除装置
  • 用于栓塞的球囊导管
  • 经皮血栓切除装置
  • 导管导引溶栓(CDT)装置
  • 下腔静脉滤网(IVCF)

第五章 全球血栓管理器材市场:依经经皮切除器械类型划分

  • 市场分析、洞察与预测
  • 吸力式血栓清除装置
  • 经皮机械血栓切除装置

第六章 全球血栓管理设备市场:依最终用途划分

  • 市场分析、洞察与预测
  • 诊断中心
  • 医院

第七章 全球血栓管理设备市场:依地区划分

  • 区域分析
  • 北美市场分析、洞察与预测
    • 我们
    • 加拿大
    • 墨西哥
  • 欧洲市场分析、洞察与预测
    • 英国
    • 法国
    • 德国
    • 义大利
    • 俄罗斯
    • 其他欧洲国家
  • 亚太市场分析、洞察与预测
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 东南亚
    • 其他亚太国家
  • 拉丁美洲市场分析、洞察与预测
    • 巴西
    • 阿根廷
    • 秘鲁
    • 智利
    • 其他拉丁美洲国家
  • 中东和非洲市场分析、洞察与预测
    • 沙乌地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中东和非洲国家

第八章 竞争情势

  • 最新趋势
  • 公司分类
  • 供应链和销售管道合作伙伴(根据现有资讯)
  • 市场占有率和市场定位分析(基于现有资讯)
  • 供应商情况(基于现有资讯)
  • 策略规划

第九章:公司简介

  • 主要公司的市占率分析
  • 公司简介
    • Medtronic
    • Boston Scientific Corporation
    • IVascular SLU
    • Teleflex Inc
    • Edwards Lifesciences Corporation
    • LeMaitre Vascular Inc
    • Vascular Solutions Inc
    • Straub Medical AG
    • Cook Medical
    • DePuy Synthes
简介目录
Product Code: VMR112115462

The Clot Management Devices Market size is expected to reach USD 2.73 Billion in 2034 from USD 1.71 Billion (2025) growing at a CAGR of 5.34% during 2026-2034.

The Global Clot Management Devices Market is witnessing strong growth due to the increasing prevalence of cardiovascular diseases and thrombotic disorders. Blood clots can lead to serious medical conditions such as stroke, pulmonary embolism, and deep vein thrombosis, making effective clot removal and management essential in emergency medical care. Clot management devices are widely used in interventional procedures to remove or dissolve clots and restore normal blood flow.

Technological innovations have significantly improved the performance and safety of clot management devices. Mechanical thrombectomy systems, aspiration catheters, and clot retrieval devices are enabling physicians to treat clot-related conditions with greater precision and speed. The increasing adoption of minimally invasive treatment techniques is further supporting the growth of this market.

Looking ahead, the Global Clot Management Devices Market is expected to expand as healthcare providers continue to focus on advanced cardiovascular treatment solutions. Manufacturers are developing next-generation devices that improve clot removal efficiency while reducing procedural risks. With the rising incidence of stroke and other clot-related conditions, the demand for effective clot management technologies is projected to grow significantly.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • Neurovascular Embolectomy Devices
  • Embolectomy Balloon Catheters
  • Percutaneous Thrombectomy Devices
  • Catheter-Directed Thrombolysis (CDT) devices
  • Inferior vena cava filters (IVCF)

By Percutaneous Thrombectomy Devices Type

  • Aspiration Thrombectomy Devices
  • Percutaneous Mechanical Thrombectomy Devices

By End-use

  • Diagnostic centers
  • Hospitals

COMPANIES PROFILED

  • Medtronic, Boston Scientific Corporation, iVascular SLU, Teleflex Inc, Edwards Lifesciences Corporation, LeMaitre Vascular Inc, Vascular Solutions Inc, Straub Medical AG, Cook Medical, DePuy Synthes
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CLOT MANAGEMENT DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Neurovascular Embolectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Embolectomy Balloon Catheters Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Percutaneous Thrombectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Catheter-Directed Thrombolysis (CDT) devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Inferior vena cava filters (IVCF) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CLOT MANAGEMENT DEVICES MARKET: BY PERCUTANEOUS THROMBECTOMY DEVICES TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Percutaneous Thrombectomy Devices Type
  • 5.2. Aspiration Thrombectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Percutaneous Mechanical Thrombectomy Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CLOT MANAGEMENT DEVICES MARKET: BY END-USE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-use
  • 6.2. Diagnostic centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CLOT MANAGEMENT DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Percutaneous Thrombectomy Devices Type
    • 7.2.3 By End-use
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Percutaneous Thrombectomy Devices Type
    • 7.3.3 By End-use
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Percutaneous Thrombectomy Devices Type
    • 7.4.3 By End-use
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Percutaneous Thrombectomy Devices Type
    • 7.5.3 By End-use
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Percutaneous Thrombectomy Devices Type
    • 7.6.3 By End-use
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CLOT MANAGEMENT DEVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Medtronic
    • 9.2.2 Boston Scientific Corporation
    • 9.2.3 IVascular SLU
    • 9.2.4 Teleflex Inc
    • 9.2.5 Edwards Lifesciences Corporation
    • 9.2.6 LeMaitre Vascular Inc
    • 9.2.7 Vascular Solutions Inc
    • 9.2.8 Straub Medical AG
    • 9.2.9 Cook Medical
    • 9.2.10 DePuy Synthes